Área: Biblioteca del área

Inusual case of Rosai-Dorfman disease in a 18F-FDG PET/CT study. Rev Esp Med Nucl Imagen Mol. 2020 Mar-Apr;39(2):108-109. doi: 10.1016/j.remn.2019.12.005. Epub 2020 Feb 3.PMID: 32029412English, Spanish.No abstract available.F.I.:0.928

Oscillopsia in Bilateral Vestibular Hypofunction: Not Only Gain But Saccades Too. Ear Hear. 2020 Mar/Apr;41(2):323-329. doi: 10.1097/AUD.0000000000000760. PMID: 31517671.F.:2.954

RISK FACTORS FOR HYPOGLYCEMIA IN INPATIENTS WITH TOTAL PARENTERAL NUTRITION AND TYPE 2 DIABETES: A POST-HOC ANALYSIS OF THE INSUPAR STUDY. Endocr Pract. 2020 Mar 11. doi: 10.4158/EP-2019-0482. Epub ahead of print. PMID: 32160049.F.I.:2.170

Long-Term Dislocation of the Mandible: Is there an Algorithm to Success? Intraoperative Decision and Review of Literature. J Maxillofac Oral Surg. 2020 Mar;19(1):12-16. doi: 10.1007/s12663-019-01312-y. Epub 2019 Dec 2. PMID: 31988556; PMCID: PMC6954913.F.I.:1.781

Recommendations for the management of renal involvement in the tuberous sclerosis complex. Nefrologia. 2020 Mar-Apr;40(2):142-151. doi: 10.1016/j.nefro.2019.07.002. Epub 2019 Nov 10.PMID: 31722796English, Spanish.F.I.:1.439

Haemophagocytic syndrome associated with infections: Not so uncommon. Rev Clin Esp. 2020 Mar;220(2):109-114. English, Spanish. doi: 10.1016/j.rce.2019.04.008. Epub 2019 Jun 13. PMID: 31202502.F.I.:1.043

When can it be useful to look for occult HBV in hemodialysis patients? Nefrologia. 2020 Mar-Apr;40(2):115-119. doi: 10.1016/j.nefro.2019.07.001. Epub 2019 Sep 21.PMID: 31551120English, Spanish.No abstract available.F.I.:1.439

Factors that determine the loss of control when reducing therapy by steps in the treatment of moderate-severe asthma in standard clinical practice: A multicentre Spanish study. Rev Clin Esp. 2020 Mar;220(2):86-93. English, Spanish. doi: 10.1016/j.rce.2019.05.004. Epub 2019 Jul 23. PMID: 31350049.F.I.:1.043

[Back pain: A case with an uncommon presentation]. Semergen. 2020 Feb 10:S1138-3593(20)30002-2. Spanish. doi: 10.1016/j.semerg.2019.12.003. Epub ahead of print. PMID: 32057634.F.I:0.171

Effectiveness of Fingolimod versus Natalizumab as Second-Line Therapy for Relapsing-Remitting Multiple Sclerosis in Spain: Second-Line GATE Study. Eur Neurol. 2020 Mar 18:1-9. doi: 10.1159/000505778. Epub ahead of print. PMID: 32187609.F.I.4.387.